Tag: CEO

Heart Repair Technologies, Inc. Appoints David H. Chung as Chief Executive Officer

SAN JOSE, Calif.–(BUSINESS WIRE)–Heart Repair Technologies, Inc. (“HRT” or “Company”), a privately-held medical device company specializing in disruptive mitral and tricuspid valve repair technology to resolve heart valve regurgitation in heart failure patients, today announced that David H. Chung has been appointed Chief Executive Officer (CEO), effective as of October […]

Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism

August 15, 2024 10:00 AM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal ControlTM to bring the precision and control of direct surgical access to catheter-based interventions, announced today that it has exited stealth mode with a […]

HOPPR appoints world-renowned radiologist and AI pioneer, Dr. Khan M. Siddiqui, as CEO

CHICAGO, Sept. 19, 2023 /PRNewswire/ — In a groundbreaking move, HOPPR, an AI company that is changing medical imaging forever by enabling a GPT-4-like interaction with medical imaging studies, is proud to announce the appointment of Dr. Khan Siddiqui as its Chief Executive Officer. The original pioneer of radiology informatics, a world […]

Protaryx Medical Welcomes David Mester as New CEO to Spearhead Advancements in Transseptal Access Technology

BALTIMORE–(BUSINESS WIRE)–Protaryx Medical, a pioneer in medical device innovation, today announced the appointment of David Mester, MBA as its new chief executive officer (CEO). With a career spanning over 33 years in the structural heart medical device industry, Mester brings a wealth of experience and expertise to guide Protaryx into […]

Corvidia Therapeutics Appoints Marc de Garidel as Chief Executive Officer

WALTHAM, Mass.–(BUSINESS WIRE)– Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, today announced the appointment of Marc de Garidel as Chief Executive Officer. Mr. de Garidel succeeds Corvidia’s Michael Davidson, M.D., who will remain on the company’s executive team as Chief Scientific Officer. “As we transition from a clinical stage […]

Endospan Appoints Kevin J. Mayberry as CEO

HERZLIA, Israel–(BUSINESS WIRE)–Endospan, a pioneer in off-the-shelf endovascular repair of Aortic Arch Disease including aneurysms and dissections, today announced that it has appointed Kevin J. Mayberry as Chief Executive Officer (CEO), effective immediately. He replaces Alon Shalev, who will continue as a director of Endospan. Previously, Mayberry served in various R&D and […]